Tirzepatide, a dual glucagon-like peptide-1 (GIP) and GLP-1RAs, administered once weekly at a 15 mg dose, resulted in an average weight loss of 20.9% over 72 weeks (Jastreboff et al., 2022), driven by its synergistic effects on appetite regulation, energy intake reduction, and fat mass decrease (Heise et al., 2023)
Compra Verificada Zumub Me gust esta opinin
Eligible patients were randomized in a 1:1:1:2 ratio into one of four treatment groups: GIC-1001 at doses of 250 mg, 375 mg, or 500 mg, and a matching placebo group
Kendall DM, Riddle MC, Rosenstock J, et al
Khng nn s dng Glutathione v Vitamin C thay th cho ch n ung v li sng lnh mnh